Introduction. Dihydro derivatives of pyrazolo-[1,5-a]pyrimidine have high physiological activity, the most important being cardiovascular activity (Tsuda, Mishina, Obata, Inui & Nakamura, 1986) . Though chemical and physiological characteristics of these componds are directly defined by the conformation of their molecules, relevant data on the spatial structure of the dihydropyrazolo[2,3-a]pyrimidines are not available. The present paper is a continuation of our investigation of the molecular and crystal structures of dihydropyrazolopyrimidines containing a bridgehead nitrogen (Orlov, Desenko, Potekhin & Struchkov, 1988) and is devoted to an X-ray diffraction study of 2-methyl-5,6,7-triphenyl-6, 7-dihydropyrazolo[2,3-a] pyrimidine (1).
Experimental. The title compound was prepared by the method described by Orlov, Quiroga, Kolos & Desenko, (1988) . Crystals of (I) as pale-yellow plates of approximate dimensions 0.10 x 0.15 x 0.20 mm, 0108-2701/93/050896-03$06.00 suitable for an X-ray study, were grown from a 2-propanol solution by slow evaporation of the solvent. A Siemens P3/PC diffractometer with graphitemonochromated Mo Ka radiation was used. The unit-cell parameters were determined by leastsquares fit of setting angles of 9 automatically centred reflections (24 < (} < 26°). The 8/28 scan technique with a variable scan speed (2.0 to 30.0° min-1 ) was used. Two check reflections were monitored after every 50 measurements and they showed no systematic variation in intensity. 2775 reflections up to 28 = 56.0° were measured including the check and equivalent reflections, with 0 < h < 12, 0 < k < 26, -11 < l < 11. Of 2640 unique reflections (Rint = 0.023), 2467 reflections had I> 2u(l). Only Lp corrections were applied.
The structure was solved by direct methods using the SHELXTL-Plus (Siemens, 1990) 
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The final atomic parameters are listed in Table I .* Atomic scattering factors from International Tables for X-ray Crystallography (1974, Vol. IV) were used.
Discussion
. Fig. 1 . shows a perspective view of molecule (I) with the atom-numbering scheme. Bond lengths, angles and selected torsion angles are listed in Table 2 . The N(3)-C(4) and C(4)-C(5) bond lengths [1.294 (7) and 1.533 (9) A] and the presence of an H atom at C(5) but not at N(3) suggest the imine tautomeric structure of (I) in contrast to dihydro[ 1 ,2,4]triazolo[2,3-a ]pyrimidines, which crystallize as enamines (Orlov, Desenko et al., 1988) . The C(6)-C(19) and C(5)-C(l3) bonds [1.532 (9) and 1.568 (9) A] are somewhat longer than the standard value of 1.503 A (Allen et al., 1987 The torsion angles indicate that the pyrazole ring in (I) is planar. The conformation of the dihydropyrimidine ring can be described as a distorted sofa with the C(5) atom displaced most from the plane of the ring [puckering coordinates (Zefirov, Palyulin & Dashevskaya, 1990) A stereoscopic view of the unit cell is shown in Fig. 2 . There are no intermolecular distances shorter than the sums of the van der Waals radii.
